Literature DB >> 23896203

Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome.

Zeljka Korade1, Libin Xu2, Fiona E Harrison3, Refayat Ahsen4, Sarah E Hart4, Oakleigh M Folkes5, Károly Mirnics1, Ned A Porter6.   

Abstract

BACKGROUND: Smith-Lemli-Opitz syndrome (SLOS) is an inborn error of cholesterol biosynthesis characterized by diminished cholesterol and increased 7-dehydrocholesterol (7-DHC) levels. 7-Dehydrocholesterol is highly reactive, giving rise to biologically active oxysterols.
METHODS: 7-DHC-derived oxysterols were measured in fibroblasts from SLOS patients and an in vivo SLOS rodent model using high-performance liquid chromatography tandem mass spectrometry. Expression of lipid biosynthesis genes was ascertained by quantitative polymerase chain reaction and Western blot. The effects of an antioxidant mixture of vitamin A, coenzyme Q10, vitamin C, and vitamin E were evaluated for their potential to reduce formation of 7-DHC oxysterols in fibroblast from SLOS patients. Finally, the effect of maternal feeding of vitamin E enriched diet was ascertained in the brain and liver of newborn SLOS mice.
RESULTS: In cultured human SLOS fibroblasts, the antioxidant mixture led to decreased levels of the 7-DHC-derived oxysterol, 3β,5α-dihydroxycholest-7-en-6-one. Furthermore, gene expression changes in SLOS human fibroblasts were normalized with antioxidant treatment. The active ingredient appeared to be vitamin E, as even at low concentrations, it significantly decreased 3β,5α-dihydroxycholest-7-en-6-one levels. In addition, analyzing a mouse SLOS model revealed that feeding a vitamin E enriched diet to pregnant female mice led to a decrease in oxysterol formation in brain and liver tissues of the newborn Dhcr7-knockout pups.
CONCLUSIONS: Considering the adverse effects of 7-DHC-derived oxysterols in neuronal and glial cultures and the positive effects of antioxidants in patient cell cultures and the transgenic mouse model, we believe that preventing formation of 7-DHC oxysterols is critical for countering the detrimental effects of DHCR7 mutations.
Copyright © 2014 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  7-dehydrocholesterol; Antioxidants; DHCEO; Dhcr7; Smith-Lemli-Opitz Syndrome; oxysterol

Mesh:

Substances:

Year:  2013        PMID: 23896203      PMCID: PMC3874268          DOI: 10.1016/j.biopsych.2013.06.013

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  47 in total

1.  A NEWLY RECOGNIZED SYNDROME OF MULTIPLE CONGENITAL ANOMALIES.

Authors:  D W SMITH; L LEMLI; J M OPITZ
Journal:  J Pediatr       Date:  1964-02       Impact factor: 4.406

2.  Vitamin E (tocopherol) in human fetuses and placentae.

Authors:  M Y DJU; K E MASON; L J FILER
Journal:  Etudes Neonatales       Date:  1952-09

Review 3.  Free radical lipid peroxidation: mechanisms and analysis.

Authors:  Huiyong Yin; Libin Xu; Ned A Porter
Journal:  Chem Rev       Date:  2011-08-23       Impact factor: 60.622

4.  Levels of vitamin E in the plasma of newborn infants and of the mothers.

Authors:  P J Leonard; E Doyle; W Harrington
Journal:  Am J Clin Nutr       Date:  1972-05       Impact factor: 7.045

5.  DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model.

Authors:  Libin Xu; Karoly Mirnics; Aaron B Bowman; Wei Liu; Jennifer Da; Ned A Porter; Zeljka Korade
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

Review 6.  Modulation of signal transduction by vitamin E.

Authors:  Jean-Marc Zingg
Journal:  Mol Aspects Med       Date:  2007-01-12

7.  Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions.

Authors:  J K Lang; K Gohil; L Packer
Journal:  Anal Biochem       Date:  1986-08-15       Impact factor: 3.365

8.  Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome.

Authors:  G S Tint; M Seller; R Hughes-Benzie; A K Batta; S Shefer; D Genest; M Irons; E Elias; G Salen
Journal:  J Lipid Res       Date:  1995-01       Impact factor: 5.922

9.  Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice.

Authors:  F E Harrison; J Allard; R Bixler; C Usoh; L Li; J M May; M P McDonald
Journal:  Nutr Neurosci       Date:  2009-10       Impact factor: 4.994

Review 10.  The European perspective on vitamin E: current knowledge and future research.

Authors:  Regina Brigelius-Flohé; Frank J Kelly; Jukka T Salonen; Jiri Neuzil; Jean-Marc Zingg; Angelo Azzi
Journal:  Am J Clin Nutr       Date:  2002-10       Impact factor: 7.045

View more
  25 in total

1.  Identification of Environmental Quaternary Ammonium Compounds as Direct Inhibitors of Cholesterol Biosynthesis.

Authors:  Josi Herron; Rosalyn C Reese; Keri A Tallman; Rohini Narayanaswamy; Ned A Porter; Libin Xu
Journal:  Toxicol Sci       Date:  2016-02-26       Impact factor: 4.849

2.  Desmosterolosis and desmosterol homeostasis in the developing mouse brain.

Authors:  Luke B Allen; Thiago C Genaro-Mattos; Ned A Porter; Károly Mirnics; Zeljka Korade
Journal:  J Inherit Metab Dis       Date:  2019-04-08       Impact factor: 4.982

3.  Birthday of a syndrome: 50 years anniversary of Smith-Lemli-Opitz Syndrome.

Authors:  Martina Witsch-Baumgartner; Barbara Lanthaler
Journal:  Eur J Hum Genet       Date:  2014-05-14       Impact factor: 4.246

4.  Statins for Smith-Lemli-Opitz syndrome.

Authors:  Rami A Ballout; Simona Bianconi; Alicia Livinski; Yi-Ping Fu; Alan T Remaley; Forbes D Porter
Journal:  Cochrane Database Syst Rev       Date:  2020

Review 5.  Free radical oxidation of cholesterol and its precursors: Implications in cholesterol biosynthesis disorders.

Authors:  L Xu; N A Porter
Journal:  Free Radic Res       Date:  2014-12-09

6.  7-Dehydrocholesterol (7-DHC), But Not Cholesterol, Causes Suppression of Canonical TGF-β Signaling and Is Likely Involved in the Development of Atherosclerotic Cardiovascular Disease (ASCVD).

Authors:  Shuan Shian Huang; I-Hua Liu; Chun-Lin Chen; Jia-Ming Chang; Frank E Johnson; Jung San Huang
Journal:  J Cell Biochem       Date:  2016-12-13       Impact factor: 4.429

7.  Inhibitors of 7-Dehydrocholesterol Reductase: Screening of a Collection of Pharmacologically Active Compounds in Neuro2a Cells.

Authors:  Hye-Young H Kim; Zeljka Korade; Keri A Tallman; Wei Liu; C David Weaver; Karoly Mirnics; Ned A Porter
Journal:  Chem Res Toxicol       Date:  2016-04-28       Impact factor: 3.739

Review 8.  Regulated necrosis: disease relevance and therapeutic opportunities.

Authors:  Marcus Conrad; José Pedro Friedmann Angeli; Peter Vandenabeele; Brent R Stockwell
Journal:  Nat Rev Drug Discov       Date:  2016-01-18       Impact factor: 84.694

9.  Altered cerebrospinal fluid proteins in Smith-Lemli-Opitz syndrome patients.

Authors:  Stephanie M Cologna; Christine Shieh; Cynthia L Toth; Antony Cougnoux; Kathryn R Burkert; Simona E Bianconi; Christopher A Wassif; Forbes D Porter
Journal:  Am J Med Genet A       Date:  2016-05-05       Impact factor: 2.802

10.  Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol.

Authors:  Phillip A Wages; Hye-Young H Kim; Zeljka Korade; Ned A Porter
Journal:  J Lipid Res       Date:  2018-08-07       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.